Cargando…
Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence
Community-acquired pneumonia (CAP) is a common infection with a constantly evolving etiological spectrum. This changing etiology conditions the adequate selection of optimal therapeutic regimens, both in empirical and definitive treatments. In recent years, new antimicrobials have been approved by r...
Autores principales: | Sellarès-Nadal, Juilia, Burgos, Joaquin, Falcó, Vicenç, Almirante, Benito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682597/ https://www.ncbi.nlm.nih.gov/pubmed/33239925 http://dx.doi.org/10.2147/JEP.S259286 |
Ejemplares similares
-
Community-acquired pneumonia in hospitalised patients: changes in aetiology, clinical presentation, and severity outcomes in a 10-year period
por: Sellarès-Nadal, Júlia, et al.
Publicado: (2022) -
Epidemiology and Long-Term Survival in HIV-Infected Patients With Pneumocystis jirovecii Pneumonia in the HAART Era: Experience in a University Hospital and Review of the Literature
por: López-Sánchez, Cristina, et al.
Publicado: (2015) -
Periprosthetic Joint Infection Prophylaxis in the Elderly after Hip Hemiarthroplasty in Proximal Femur Fractures: Insights and Challenges
por: Rodríguez-Pardo, Dolors, et al.
Publicado: (2021) -
Hot topics and current controversies in community-acquired pneumonia
por: Severiche-Bueno, Diego, et al.
Publicado: (2019) -
Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)